Clinical efficacy of potassium humate in the treatment of allergic rhinitis: double-blind placebo-controlled trial.
- Published in:
- Drug Development Research, 2010, v. 71, n. 6, p. 358, doi. 10.1002/ddr.20381
- By:
- Publication type:
- Article
Works matching IS 02724391 AND DT 2010 AND VI 71 AND IP 6
Results: 6
1
2
Clavulanic acid protects neurons in pharmacological models of neurodegenerative diseases.
- Published in:
- Drug Development Research, 2010, v. 71, n. 6, p. 351, doi. 10.1002/ddr.20378
- By:
- Publication type:
- Article
3
Targeting the development of resveratrol as a chemopreventive agent.
- Published in:
- Drug Development Research, 2010, v. 71, n. 6, p. 335, doi. 10.1002/ddr.20380
- By:
- Publication type:
- Article
4
Anti-anxiety and sedative profile evaluation of imidazo[1,2- a]pyridine derivatives.
- Published in:
- Drug Development Research, 2010, v. 71, n. 6, p. 371, doi. 10.1002/ddr.20382
- By:
- Publication type:
- Article
5
Toward a better understanding of depression and anxiety. The importance of tryptophan hydroxylase activation blockade: The origin of a unique anxiolytic antidepressant.
- Published in:
- Drug Development Research, 2010, v. 71, n. 6, p. 331, doi. 10.1002/ddr.20386
- By:
- Publication type:
- Article
6
Bioevaluation of a novel [<sup>32</sup>P]-CP-PLLA microparticle for pancreatic cancer treatment.
- Published in:
- Drug Development Research, 2010, v. 71, n. 6, p. 364, doi. 10.1002/ddr.20379
- By:
- Publication type:
- Article